Dave Gardner

Företagsledare/Principal på INCYTE CORPORATION

Förmögenhet: 1 M $ per 2026-06-30

43 år

86 relationer

Health Technology

Finance

Consumer Services

Profil

Dave Gardner is Chief Strategy Officer & Executive Vice President at Incyte Corp.
since 2025.
Former roles include Director at Xilio Therapeutics, Inc., Vice President at BlackRock Finance, Inc. from 2006 to 2015, and Analyst at Rock Springs Capital Management LP from 2015 to 2025.
Education includes an MBA from Columbia Business School conferred in 2015 and an undergraduate degree from McIntire School of Commerce.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
INCYTE CORPORATION 0 %	2025-09-22	9 429 ( 0 % )	1 M $	2026-06-30

Aktiva positioner av Dave Gardner

Företag	Position	Start
INCYTE CORPORATION	Företagsledare/Principal	2025-09-22

Alla aktiva positioner av Dave Gardner

Tidigare kända positioner av Dave Gardner

Företag	Position	Slut
Rock Springs Capital Management LP Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing.	Analyst-Equity	2025-09-01
BlackRock Finance, Inc. BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions	Företagsledare/Principal	2015-05-01
XILIO THERAPEUTICS, INC.	Direktör/Styrelseledamot	-

Se detaljerna i Dave Gardners erfarenhet

Dave Gardners utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Dave Gardners erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	6
Incyte Corp. Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics	Health Technology
BlackRock Finance, Inc. BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions	Finance
Rock Springs Capital Management LP Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing.	Finance
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
McIntire School of Commerce McIntire School of Commerce Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology